US · Healthcare · Medical Instruments & Supplies
EPS came in at 3.00 against a street estimate of 2.13 — a beat of 40.8%.
Analysts rate Intuitive Surgical Inc a buy (26 buy, 6 hold, 2 sell out of 34) with an average price target of $482.63.
CONFIDENT Intuitive delivered strong Q3 growth, led by global procedures, placements, da Vinci 5, SP and Ion. Management raised procedure and margin outlook, while planned pricing actions will reduce future revenue per procedure. Q3 FY26 International growth outpaced the U.S.; benign procedures outside the U.S. grew 41%, while China remained operationally challenging. Analysts focused on U.S. procedure deceleration, extended-use pricing, ASC growth, pipeline products, margins and the settlement. Management emphasized difficult comparisons, phased implementation and continued long-term investment. 2026-10-20…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.45% |
| Vanguard Capital Management, LLC | 6.51% |
| State Street Corp | 4.52% |
| Amvescap Plc. | 3.33% |
| T. Rowe Price Associates, Inc. | 3.17% |
| Geode Capital Management, LLC | 2.40% |
| Capital World Investors | 2.18% |
| Vanguard Portfolio Management, LLC | 2.04% |
| Document | Date |
|---|---|
| Board / officer change · Q4 2026 OTHER NOTABLE POINTS • Intuitive Surgical’s board approved an increase in its size from ten to eleven members. • Aaron Martin was appointed as an in | 2026-11-02 |
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $3,048.7 million, up from $2,505.1 million in the third quarter of 2025. • Nine-month 2026 revenue | 2026-10-21 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Q3 2026 revenue was $3.05 billion, up 22% from $2.51 billion in Q3 2025. • GAAP net income attributable to Intuitive was $523 mil | 2026-10-20 |
| Charter / bylaws change · Q3 2026 INTUITIVE SURGICAL, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Document date: July 23, 2026 • Company: Intuitive Surgical, Inc. (NASDAQ: ISRG) • Fil | 2026-07-27 |
| Quarterly report · Q2 2026 INTUITIVE SURGICAL, INC. - Q2 2026 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Total Revenue (6 months): $5,663.1 million, up 20.7% vs. $4,693.4 | 2026-07-21 |
| Results announced · Q3 2026 INTUITIVE SURGICAL Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Revenue: $2.89 billion, up 19% vs Q2 2025 ($2.44 billion) • Q2 2026 GAAP Net | 2026-07-16 |
| Board / officer change · Q2 2026 INTUITIVE SURGICAL, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Filing Date: May 28, 2026 • Company: Intuitive Surgical, Inc. (Ticker: ISRG, Nasdaq) | 2026-05-28 |
| Board / officer change · Q2 2026 INTUITIVE SURGICAL, INC. - FORM 8-K SUMMARY Filing Date: May 4, 2026 | Annual Meeting: April 30, 2026 --- HEADLINE NUMBERS • Stock repurchase progr | 2026-05-04 |
Readable in the app.
| Announcement | Date |
|---|---|
| Completed acquisition of da Vinci and Ion distribution business Intuitive Surgical completed its acquisition of the da Vinci and Ion distribution business from ab medica, Abex, Excelencia Robótica, and their affiliates on March 1, 2026. The company annou | 2026-03-02 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Intuitive Surgical Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.